Profile data is unavailable for this security.
About the company
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
- Revenue in SEK (TTM)48.29m
- Net income in SEK-53.73m
- Incorporated2000
- Employees--
- LocationAroCell AB (publ)Karlsbodavagen 39BROMMA 168 67SwedenSWE
- Phone+46 87996750
- Websitehttps://arocell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCI Biotech Holding ASA | 5.79m | -15.44m | 63.04m | 7.00 | -- | 2.05 | -- | 10.89 | -0.4287 | -0.4287 | 0.1607 | 0.8548 | 0.1334 | -- | 0.9365 | 857,000.00 | -35.59 | -36.44 | -40.42 | -40.14 | -- | -- | -266.74 | -1,055.43 | -- | -- | 0.0147 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
Chosa Oncology AB | 5.00k | -8.58m | 66.26m | -- | -- | 3.06 | -- | 13,252.37 | -0.1745 | -0.1745 | 0.00009 | 0.3054 | 0.0002 | -- | 0.0009 | -- | -28.72 | -51.96 | -31.51 | -61.92 | -- | -- | -171,540.00 | -708.47 | -- | -28.22 | 0.00 | -- | -98.21 | -- | 28.33 | -- | -- | -- |
Orphazyme A/S | 0.00 | -17.41m | 76.78m | 1.00 | -- | 2.65 | -- | -- | -325.75 | -325.75 | 0.00 | 455.65 | 0.00 | -- | -- | 0.00 | -42.26 | -76.08 | -50.77 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
Klaria Pharma Holding AB (publ) | -6.53m | -18.21m | 77.60m | 5.00 | -- | 3.73 | -- | -- | -0.1594 | -0.4121 | -0.0605 | 0.1603 | -0.0864 | -- | -- | -1,305,600.00 | -24.10 | -37.28 | -44.74 | -51.56 | -- | -- | -- | -2,077.34 | -- | -0.439 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
Coegin Pharma AB | 0.00 | -26.00m | 81.37m | 1.00 | -- | 3.78 | -- | -- | -2.25 | -2.25 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -111.12 | -122.02 | -119.99 | -154.70 | -- | -- | -- | -28,466.75 | -- | -55.53 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
Dextech Medical AB | 0.00 | -4.71m | 82.45m | 1.00 | -- | 2.78 | -- | -- | -0.2545 | -0.2545 | 0.00 | 1.60 | 0.00 | -- | -- | 0.00 | -14.34 | -23.30 | -14.72 | -23.93 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.51 | -- | 18.92 | -- |
Spago Nanomedical AB (publ) | 1.81m | -35.86m | 82.87m | 12.00 | -- | 1.66 | -- | 45.76 | -0.2614 | -0.2614 | 0.0106 | 0.1436 | 0.0386 | -- | 2.43 | 139,307.70 | -76.46 | -20.19 | -86.74 | -20.97 | -97.96 | -- | -1,980.40 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
Prolight Diagnostics AB (publ) | 0.00 | -140.00m | 93.77m | 16.00 | -- | 0.6417 | -- | -- | -0.3853 | -0.3853 | 0.00 | 0.2447 | 0.00 | -- | -- | 0.00 | -66.82 | -- | -89.89 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -13.84 | -- |
Sprint Bioscience AB | 85.01m | 14.72m | 96.49m | 36.00 | 6.56 | 5.16 | 6.23 | 1.14 | 0.2108 | 0.2108 | 1.22 | 0.2677 | 2.38 | -- | 13.18 | 3,036,214.00 | 41.28 | -71.22 | 128.58 | -113.71 | 76.51 | 62.75 | 17.31 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
Active Biotech AB publ | 0.00 | -44.20m | 107.07m | 8.00 | -- | 11.16 | -- | -- | -0.1564 | -0.1564 | 0.00 | 0.0265 | 0.00 | -- | -- | -- | -189.29 | -57.97 | -322.63 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1933 | -- | -- | -- | 21.54 | -- | -- | -- |
Biosergen AB | 0.00 | -26.60m | 118.24m | 2.00 | -- | 7.65 | -- | -- | -0.286 | -0.286 | 0.00 | 0.0557 | 0.00 | -- | -- | 0.00 | -145.58 | -- | -216.30 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.25 | -- | -- | -- |
AroCell AB (publ) | 48.29m | -53.73m | 119.79m | -- | -- | 0.8553 | -- | 2.48 | -0.2333 | -0.2333 | 0.2096 | 0.608 | -- | -- | -- | -- | -- | -29.25 | -- | -31.37 | 8.63 | -9.85 | -111.28 | -231.19 | 4.61 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
NextCell Pharma AB | 11.85m | -37.28m | 153.49m | -- | -- | 1.94 | -- | 12.95 | -0.8565 | -0.8565 | 0.2723 | 1.08 | 0.1512 | 44.63 | 7.34 | -- | -47.56 | -34.92 | -54.11 | -37.06 | -193.25 | -349.19 | -314.54 | -538.60 | 3.75 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
AlzeCure Pharma AB | 0.00 | -35.87m | 163.35m | 11.00 | -- | 4.00 | -- | -- | -0.5371 | -0.5371 | 0.00 | 0.4625 | 0.00 | -- | -- | 0.00 | -75.21 | -52.78 | -89.05 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
Exact Therapeutics AS | 0.00 | -52.92m | 178.01m | 12.00 | -- | 10.58 | -- | -- | -1.66 | -1.66 | 0.00 | 0.5435 | 0.00 | -- | -- | -- | -130.29 | -40.21 | -170.98 | -45.67 | -- | -- | -- | -- | -- | -- | 0.0502 | -- | -- | -- | -20.52 | -- | -- | -- |
Data as of Oct 10 2024. Currency figures normalised to AroCell AB (publ)'s reporting currency: Swedish Krona SEK
Holder | Shares | % Held |
---|---|---|
Arvernus Capital AGas of 30 Sep 2023 | 440.49k | 0.19% |
Data from 30 Sep 2023 - 30 Sep 2023Source: FactSet Research Systems Inc.